Current position:Home >Product >
1H-1,2,4-Triazole, 1-[[2-(2,4-difluorophenyl)tetrahydro-4-[(phenylmethoxy)methyl]-2-furanyl]methyl]-, (2R-cis)- (9CI)
1H-1,2,4-Triazole, 1-[[2-(2,4-difluorophenyl)tetrahydro-4-[(phenylmethoxy)methyl]-2-furanyl]methyl]-, (2R-cis)- (9CI)(165115-83-3)
- Name: 1H-1,2,4-Triazole, 1-[[2-(2,4-difluorophenyl)tetrahydro-4-[(phenylmethoxy)methyl]-2-furanyl]methyl]-, (2R-cis)- (9CI)
- Synonyms:PosacozoleImpurity66;Posaconazole Impurity 91;Posaconazole Impurity 94;1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole;1H-1,2,4-Triazole, 1-[[2-(2,4-difluorophenyl)tetrahydro-4-[(phenylmethoxy)methyl]-2-furanyl]methyl]-, (2R-cis)- (9CI)
- Molecular Formula:C21 H21 F2 N3 O2
- Molecular Weight:385.41
- CAS Registry Number:165115-83-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 615580-69-3/Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5α)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), mixt. with α-methyl-4-(2-methylpropyl)benzeneacetic acid
- 66937-88-0/2-Piperidinecarbonitrile, 4-methyl-
- 1314979-77-5/Pyridine, 1,2,3,4-tetrahydro-4-methyl-
- 172225-59-1/Quinoline, 3-methyl-, hydrochloride (1:1)
- 955032-18-5/Propanamide, 3-amino-2,2-dimethyl-, hydrochloride (1:1)
- 1230487-11-2/Pneumocandin B0, 1-[(4R,5R)-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-5-[(4-methylphenyl)thio]-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-
- 38925-79-0/Adenosine, 2-chloro-2'-deoxy-, 3',5'-bis(4-methylbenzoate)
- 79120-55-1/α-D-Ribofuranoside, methyl 5-deoxy-
- 656236-93-0/α-D-Ribofuranoside, methyl 5-deoxy-5-iodo-
- 58763-00-1/α-D-Ribofuranoside, methyl 2,3-O-(1-methylethylidene)-
- 68314-27-2/5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-methoxy-7-[(4-methylbenzoyl)amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, diphenylmethyl ester, (6R-cis)- (9CI)
- 91177-27-4/5-Oxa-1-azabicyclo 4.2.0 oct-2-ene-2-carboxylic acid, 3-(chloroMethyl)-7- (4-Met
- 68313-73-5/4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-[1-(hydroxymethyl)ethenyl]-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1α,5α,6(R*)]- (9CI)
- 82468-41-5/4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[(4-methylbenzoyl)amino]-7-oxo-, diphenylmethyl ester, 4-oxide, [2S-(2α,5α,6α)]- (9CI)
- 81016-97-9/4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[(4-methylbenzoyl)amino]-7-oxo-, 4-oxide, [2S-(2α,5α,6β)]- (9CI)
- 958889-88-8/[1,1'-Biphenyl]-2,2'-diol, 5,5'-bis(1-methylethyl)-, (1R)-
- 1221410-56-5/[1,1'-Biphenyl]-2,2'-diol, 5,5'-bis(2-methylpropyl)-
- 166583-12-6/Posaconazole DiastereoisoMer interMediate 2
- 165115-82-2/Furan, 2-(2,4-difluorophenyl)tetrahydro-2-(iodomethyl)-4-[(phenylmethoxy)methyl]-, (2R-cis)- (9CI)
- 165115-83-3/1H-1,2,4-Triazole, 1-[[2-(2,4-difluorophenyl)tetrahydro-4-[(phenylmethoxy)methyl]-2-furanyl]methyl]-, (2R-cis)- (9CI)
- 160709-02-4/D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)-
- 944716-69-2/Hexanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (2S,3S)-
- 2697-80-5/Urea, N'-[(8α)-9,10-didehydro-1,6-dimethylergolin-8-yl]-N,N-diethyl-
- 196-07-6/CREATINE MALATE
- 902576-09-4/2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE
- 928672-86-0/Canagliflozin heMihydrate
- 1312928-44-1/Quinoline, 8-[4-(4,6-di-2-naphthalenyl-1,3,5-triazin-2-yl)phenyl]-
- 1421599-34-9/4-(Biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine
- 60706-97-0/9H-Cyclopenta[1,2-b:3,4-b']dipyridin-9-one (9CI)
- 67-56-1 /